Federica Pericle
Principal investigator, leads Agilvax, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$585KFederal grants as PI2 awards
1Patents grantedLatest Jul 13, 2021
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $585K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2018 | NIH | SBIR Phase II A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer | $299K | Agilvax, Inc. |
| Jul 6, 2016 | NIH | SBIR Phase I Development of a VLP-based RSV Vaccine Targeting Pre-fusion F-Protein | $287K | Agilvax, Inc. |
2 patents as inventor
- US 11059901Agilvax, Inc.Jul 13, 2021
- US Agilvax, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,283
Awards as PI#1,252
Patents#155
Companies
- Agilvax, Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.